Murano, C. et al. 2019. Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma. EXCLI Journal. 18, (Oct. 2019), 893–898. DOI:https://doi.org/10.17179/excli2019-1786.